ALX Oncology Inc. (ALXO)
0.57
-0.03 (-5.16%)
At close: Apr 25, 2025, 10:33 AM
13F Institute Ownership
Total Institutes of 93 in ALX Oncology reduced their positions with a decrease of 2 investors compared to the previous quarter. A reduction of 4.39M shares, as total invested capital declined by $14.17M with ownership percentage dropping from 86.27% to 77.93%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.211
0.21
Call Flow 212,552
83%
Put Flow 44,800
17%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Venbio Partners LLC | 18.41% | 9.7M | +0.00% | 16.2M | 9.49% |
| Redmile Group, LLC | 7.00% | 3.69M | -3.83% | 6.16M | 0.43% |
| Tang Capital Management LLC | 6.26% | 3.3M | -21.59% | 5.51M | 0.36% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.